HDAC9 and hepatocellular carcinoma: In HCC, class I HDAC1 and HDAC2 were mainly reported to be associated with poor prognosis [7,8], but inhibition of class II HDAC, HDAC4 and HDAC5 has also been reported to have significant anti-cancer effects [9,10].